Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 11/20 | 0.41 |
| ▸ | ACMSD | Q8TDX5 | 2/20 | 0.40 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 5/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL759437 | 0.89 | ACMSD (0.48) | ESR2ACMSDDEGS1ESR1CYP3A4 | |
| SCHEMBL29376163 | 0.89 | ACMSD (0.48) | ESR2ACMSDDEGS1ESR1CYP3A4 | |
| SCHEMBL22317296 | 0.87 | ESR2 (0.56) | ESR2ESR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL22317295 | 0.84 | ESR2 (0.43) | ESR2ESR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL22316997 | 0.82 | ALOX5 (0.54) | ESR2ESR1CYP3A4ALOX5KMT2A | |
| SCHEMBL18380942 | 0.82 | ALOX5 (0.54) | ESR2ESR1CYP3A4ALOX5KMT2A | |
| SCHEMBL18623947 | 0.82 | ALOX5 (0.54) | ESR2ESR1CYP3A4ALOX5KMT2A | |
| SCHEMBL22317301 | 0.82 | ESR2 (0.46) | ESR2ESR1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL10296816 | 0.81 | ESR2 (0.55) | ESR2DEGS1ESR1CYP3A4CYP2D6 | |
| SCHEMBL19806871 | 0.80 | ESR2 (0.41) | ESR2ACMSDDEGS1ESR1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200247739-A1 | COMPOUND, RESIN, COMPOSITION, PATTERN FORMATION METHOD, AND PURIFICATION METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-08-06 | — | — | US | disclosed |
| WO-2020145406-A1 | FILM FORMING COMPOSITION, RESIST COMPOSITION, RADIATION-SENSITIVE COMPOSITION, METHOD FOR PRODUCING AMORPHOUS FILM, RESIST PATTERN FORMATION METHOD, COMPOSITION FOR FORMING LOWER LAYER FILM FOR LITHOGRAPHY, METHOD FOR PRODUCING LOWER LAYER FILM FOR LITHOGRAPHY, AND CIRCUIT PATTERN FORMATION METHOD | 三菱瓦斯化学株式会社 | 2020-07-16 | — | — | WO | disclosed |
| WO-2020145407-A1 | POLYCYCLIC POLYPHENOL RESIN AND PRODUCTION METHOD FOR POLYCYCLIC POLYPHENOL RESIN | 三菱瓦斯化学株式会社 | 2020-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200247739-A1 | COMPOUND, RESIN, COMPOSITION, PATTERN FORMATION METHOD, AND PURIFICATION METHOD | CROCC, RDX, RBBP9 | ESR2 3012/4885ACMSD 2074/4885DEGS1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.